✦ LIBER ✦

Feasibility of interval cytoreduction following neoadjuvant chemotherapy with carboplatin, weekly paclitaxel, and bevacizumab for advanced ovarian cancer – A phase I study

✍ Scribed by Salani, R.; O’Malley, D.; Copeland, L.; Cohn, D.; Fowler, J.; Eisenhauer, E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-Line Chemotherapy with Weekly Pacl

✍ Jalid Sehouli; Dirk Stengel; Dirk Elling; Olaf Ortmann; Jens Blohmer; Hanno Ries 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Phase II Study of Neoadjuvant Weekly nab

✍ Denise A. Yardley; Eric Raefsky; Raul Castillo; Anup Lahiry; Richard LoCicero; D 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 370 KB

Feasibility and safety of carboplatin pl

✍ Angioli, Roberto; Plotti, Francesco; Luvero, Daniela; Aloisi, Alessia; Guzzo, Fe 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 216 KB

A phase II feasibility study of carbopla

✍ Harries, M; Moss, C; Perren, T; Gore, M; Hall, G; Everard, M; A'Hern, R; Gibbens 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 112 KB

Sequential chemotherapy with carboplatin

✍ G. Oskay-Özcelik; R. Chekerov; H. Sommer; E. Keil; J. Einenkel; J. Pfisterer; C. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 378 KB

A phase I study of intraperitoneal topot

✍ A.M.E. Bos; F.Y.F.L. De Vos; E.G.E. de Vries; J.H. Beijnen; H. Rosing; M.J.E. Mo 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 146 KB